Related Experiment Video

Updated: Aug 9, 2026

Engineering Antiviral Agents via Surface Plasmon Resonance
13:00

Engineering Antiviral Agents via Surface Plasmon Resonance

Published on: June 14, 2022

The CPSF30 binding site on the NS1A protein of influenza A virus is a potential antiviral target

Karen Y Twu1, Diana L Noah, Ping Rao

  • 1Institute for Cellular and Molecular Biology, Section of Molecular Genetics and Microbiology, University of Texas at Austin, 2500 Speedway, Austin, Texas 78712, USA.

Journal of Virology
|March 31, 2006
PubMed

Insights

Blocking influenza A virus NS1A protein binding to CPSF30 inhibits viral replication. This discovery offers a new target for developing antivirals against influenza A, addressing drug resistance and pandemic threats.

Area of Science:

  • Virology
  • Molecular Biology
  • Drug Discovery

Background:

  • Influenza A virus resistance to current antivirals necessitates new drug development.
  • The NS1A protein of influenza A plays a key role in viral replication by inhibiting host pre-mRNA processing.
  • Pandemic threats, such as H5N1 influenza, underscore the urgency for novel antiviral strategies.

Purpose of the Study:

  • To investigate if inhibiting the NS1A protein's interaction with CPSF30 can selectively block influenza A virus replication.
  • To identify the specific region of CPSF30 involved in binding to the NS1A protein.

Main Methods:

  • Generated MDCK cells expressing the F2F3 domain of CPSF30.
  • Assessed influenza A and B virus replication in F2F3-expressing cells.
  • Measured beta interferon (IFN-beta) mRNA production in response to infection.

Main Results:

  • Influenza A virus replication was significantly inhibited in cells expressing F2F3.
  • Influenza B virus replication was not affected, as its NS1B protein does not bind CPSF30.
  • F2F3 expression led to increased IFN-beta mRNA production during influenza A infection, indicating blocked NS1A function.

Conclusions:

  • The binding interaction between influenza A NS1A protein and CPSF30 is crucial for viral replication.
  • The F2F3 domain of CPSF30 effectively inhibits influenza A virus replication by disrupting this interaction.
  • The NS1A binding site for CPSF30 represents a promising target for developing novel influenza A antivirals.

More Related Videos

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals09:31

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals

Published on: April 15, 2017

Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit22:10

Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit

Published on: June 28, 2013

Related Concept Videos

Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...